Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types
PHASE2
This study was a pilot, safety, and pharmacokinetic study of MB-102 versus ...
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
PHASE1
Ziftomenib is an investigational drug in development for the treatment of p...
Development and Validation of a Patient Reported Experience Measure for Experimental Cancer Medicine
N/A
This is a four stage, non-interventional study to develop and pilot test a ...
Status
Completed
Location
The Christie NHS Foundation Trust
Start Date
2018-07-16
Trial ID
NCT05386602
A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC)
NA
Pancreatic cancer exhibits significant heterogeneity, which poses a major c...